Organogenesis Holdings Statistics
Total Valuation
ORGO has a market cap or net worth of $105.55 million. The enterprise value is $148.74 million.
| Market Cap | 105.55M |
| Enterprise Value | 148.74M |
Important Dates
The last earnings date was Thursday, November 5, 2026, after market close.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ORGO has 129.80 million shares outstanding. The number of shares has increased by 0.53% in one year.
| Current Share Class | 129.80M |
| Shares Outstanding | 129.80M |
| Shares Change (YoY) | +0.53% |
| Shares Change (QoQ) | +0.25% |
| Owned by Insiders (%) | 35.70% |
| Owned by Institutions (%) | 43.00% |
| Float | 61.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.30 |
| Forward PS | 0.46 |
| PB Ratio | 0.88 |
| P/TBV Ratio | 1.19 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 10.25 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.42 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.32, with a Debt / Equity ratio of 0.25.
| Current Ratio | 3.32 |
| Quick Ratio | 2.39 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -41.73% and return on invested capital (ROIC) is -25.90%.
| Return on Equity (ROE) | -41.73% |
| Return on Assets (ROA) | -11.33% |
| Return on Invested Capital (ROIC) | -25.90% |
| Return on Capital Employed (ROCE) | -24.79% |
| Weighted Average Cost of Capital (WACC) | 7.68% |
| Revenue Per Employee | $412,233 |
| Profits Per Employee | -$179,327 |
| Employee Count | 854 |
| Asset Turnover | 0.80 |
| Inventory Turnover | 3.50 |
Taxes
In the past 12 months, ORGO has paid $49.81 million in taxes.
| Income Tax | 49.81M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -79.52% in the last 52 weeks. The beta is 1.48, so ORGO's price volatility has been higher than the market average.
| Beta (5Y) | 1.48 |
| 52-Week Price Change | -79.52% |
| 50-Day Moving Average | 1.26 |
| 200-Day Moving Average | 2.30 |
| Relative Strength Index (RSI) | 28.72 |
| Average Volume (20 Days) | 1,097,601 |
Short Selling Information
The latest short interest is 15.59 million, so 12.01% of the outstanding shares have been sold short.
| Short Interest | 15.59M |
| Short Previous Month | 15.00M |
| Short % of Shares Out | 12.01% |
| Short % of Float | 25.53% |
| Short Ratio (days to cover) | 24.03 |
Income Statement
In the last 12 months, ORGO had revenue of $352.05 million and -$153.15 million in losses. Loss per share was -$1.20.
| Revenue | 352.05M |
| Gross Profit | 235.97M |
| Operating Income | -79.63M |
| Pretax Income | -85.55M |
| Net Income | -153.15M |
| EBITDA | -61.35M |
| EBIT | -79.63M |
| Loss Per Share | -$1.20 |
Balance Sheet
The company has $21.33 million in cash and $64.52 million in debt, with a net cash position of -$43.19 million or -$0.33 per share.
| Cash & Cash Equivalents | 21.33M |
| Total Debt | 64.52M |
| Net Cash | -43.19M |
| Net Cash Per Share | -$0.33 |
| Equity (Book Value) | 262.74M |
| Book Value Per Share | 0.92 |
| Working Capital | 110.48M |
Cash Flow
In the last 12 months, operating cash flow was $10.30 million and capital expenditures -$10.36 million, giving a free cash flow of -$64,000.
| Operating Cash Flow | 10.30M |
| Capital Expenditures | -10.36M |
| Depreciation & Amortization | 18.28M |
| Net Borrowing | -10.90M |
| Free Cash Flow | -64,000 |
| FCF Per Share | -$0.00 |
Margins
Gross margin is 67.03%, with operating and profit margins of -22.62% and -38.45%.
| Gross Margin | 67.03% |
| Operating Margin | -22.62% |
| Pretax Margin | -24.30% |
| Profit Margin | -38.45% |
| EBITDA Margin | -17.43% |
| EBIT Margin | -22.62% |
| FCF Margin | n/a |
Dividends & Yields
ORGO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.53% |
| Shareholder Yield | -0.53% |
| Earnings Yield | -147.97% |
| FCF Yield | -0.06% |
Analyst Forecast
The average price target for ORGO is $2.00, which is 145.94% higher than the current price. The consensus rating is "Hold".
| Price Target | $2.00 |
| Price Target Difference | 145.94% |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | -18.89% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ORGO has an Altman Z-Score of 2.2 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.2 |
| Piotroski F-Score | 2 |